Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

Hyderabad:  Chief Minister A Revanth Reddy said Hyderabad was India’s emerging hub of biotech, pharma, and medical technology innovation, with the ambition to become a $1 trillion economy by 2034. He assured total support on behalf of the State government for innovation in medical products.

Speaking at the Biodesign Innovation Summit at AIG Hospital on Sunday, the Chief Minister said Hyderabad had moved from manufacturing to innovation, driven by strong academic institutions, skill development, and industry partnerships. Assuring total government support for indigenous medical innovation to solve the nation’s medical needs, he offered access to historical medical data for innovators and researchers, while maintaining strict privacy safeguards.

“For years, our best minds have been solving problems in other countries. Now, the time has come to use our intelligence to help our own people,” he said, emphasising MedTech’s critical role in healthcare transformation.

Revanth Reddy said the Medical Devices Park at Sultanpur was India’s largest, housing over 60 global and domestic companies with infrastructure for research, testing, and manufacturing. Telangana’s ecosystem of startups, MSMEs, and global corporations makes Hyderabad a vibrant destination for Life Sciences, he added.

Related Posts

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…

India’s drug body flags 90 unapproved FDC medicines, states told to take action

The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward